BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10

• Press Releases

  GEN Announces First Patient Dosed in Phase II Clinical Trial of SUL-238 in Parkinson’s Disease

  June 8, 2026

   · 

  3 min read
• Press Releases

  AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

  June 8, 2026

   · 

  7 min read
• Press Releases

  Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

  June 8, 2026

   · 

  5 min read
• Press Releases

  Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

  June 8, 2026

   · 

  6 min read
• Press Releases

  Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes

  June 8, 2026

   · 

  4 min read
• Press Releases

  Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program

  June 8, 2026

   · 

  4 min read
• Press Releases

  People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

  June 8, 2026

   · 

  7 min read
• Press Releases

  Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

  June 8, 2026

   · 

  5 min read
• Press Releases

  Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide

  June 8, 2026

   · 

  11 min read
• Press Releases

  Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

  June 8, 2026

   · 

  7 min read